Details

Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo
ID Humar, Mojca (Author), ID Čufer, Tanja (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,15 MB)
MD5: FC691BCFDFB33501F247F274E20ADF12
PID: 20.500.12556/rul/9136d6e5-a24e-4350-b1cb-75b7537460ae

Language:Slovenian
Keywords:onkologija, nedrobnocelični karcinom pljuč, receptor za IGF tipa 1, sladkorna bolezen tip 2, stopnja preživetja, imunohistokemija, bioločki tumorski označevalci
Work type:Dissertation
Typology:2.08 - Doctoral Dissertation
Organization:MF - Faculty of Medicine
Place of publishing:Ljubljana
Publisher:[M. Humar]
Year:2017
Number of pages:49 f.
PID:20.500.12556/RUL-99262 This link opens in a new window
UDC:616.24-006-036(043.3)
COBISS.SI-ID:293271808 This link opens in a new window
Publication date in RUL:10.01.2018
Views:4086
Downloads:620
Metadata:XML DC-XML DC-RDF
:
HUMAR, Mojca, 2017, Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč : doktorsko delo [online]. Doctoral dissertation. Ljubljana : M. Humar. [Accessed 1 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=99262
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:oncology, carcinoma non-small-cell lung, receptor IGF type 1, diabetes mellitus type 2, survival rate, immunohistochemistry, biomarkers tumor

Similar documents

Similar works from RUL:
  1. Review of the treatment of advanced non-small-cell lung cancer patients with mutation in the epidermal growth factor during the years of 2010 and 2014 at the University Clinic Golnik
  2. Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
  3. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Epidermal growth factor receptor mutations and treatment of non-small-cell lung cancer
  2. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  3. Multicenter evaluation of the fully automated PCR-based Idylla EGFR Mutation Assay on formalin-fixed, paraffin-embedded Q1 tissue of human lung cancer
  4. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  5. Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer

Back